# A Study of LY3473329 in Participants With Impaired and Normal Renal Function

> **NCT05778864** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 47 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** LY3473329

## Key facts

- **NCT ID:** NCT05778864
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-17
- **Primary completion:** 2024-09-06
- **Final completion:** 2024-09-06
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05778864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05778864, "A Study of LY3473329 in Participants With Impaired and Normal Renal Function". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05778864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*